Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94582 | 0.79 | FFAR1 (0.60) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL3074561 | 0.79 | FFAR1 (0.60) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL74365 | 0.79 | FFAR1 (1.00) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL9179407 | 0.79 | FFAR1 (0.74) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL11569786 | 0.79 | FFAR1 (0.60) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| Ammonia Solution, Strong SCHEMBL6255246 | 0.77 | FFAR1 (0.95) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL15570635 | 0.77 | FFAR1 (0.95) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL15571433 | 0.77 | FFAR1 (0.95) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL15572345 | 0.77 | FFAR1 (0.95) | FFAR1ALDH1A1MAPK1KMT2ANPC1 | |
| SCHEMBL15571405 | 0.77 | FFAR1 (0.95) | FFAR1ALDH1A1MAPK1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| EP-3019473-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2020-02-19 | — | — | EP | disclosed |
| US-10488756-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-11-26 | — | — | US | disclosed |
| EP-3354641-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-07-17 | — | — | EP | disclosed |
| US-10234761-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-03-19 | — | — | US | disclosed |
| EP-2847167-B9 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| EP-3354641-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-08-01 | — | — | EP | disclosed |
| EP-2847167-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-1794240-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-06-13 | — | — | EP | disclosed |
| US-7189489-B2 | Oxime ester photoiniators having a combined structure | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-03-13 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
| US-6949678-B2 | Oxime ester photoinitiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050191567-A1 | Oxime ester photoinitiators | KUNIMOTO KAZUHIKO (JP) | 2005-09-01 | — | — | US | disclosed |
| US-20040170924-A1 | Oxime ester photoiniators having a combined structure | CIBA CORPORATION | 2004-09-02 | — | — | US | disclosed |
| US-6596445-B1 | Initiators for photopolymerization of radically polymerizable compounds | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-07-22 | — | — | US | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| US-5663212-A | Light-sensitive resin composition | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | FFAR1 1278/4885ALDH1A1 823/4885MAPK1 3939/4885 |
| US-10488756-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | FFAR1 1278/4885ALDH1A1 823/4885MAPK1 3939/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | FFAR1 1228/4885ALDH1A1 779/4885MAPK1 3920/4885 |
| US-10234761-B2 | Oxime ester photoinitiators | C9, C5, CBR3 | FFAR1 2968/4885ALDH1A1 2225/4885MAPK1 3899/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | FFAR1 1278/4885ALDH1A1 823/4885MAPK1 3939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.